Larvol Delta - Centessa-Pharmaceuticals-Announces-Poster-Presentation-of-Phase-1-Clinical-Data-for-ORX750-a-novel-orexin-receptor-2-OX2R-agonist-at-the-American-Academy-of-Neurology-AAN-2025-Annual-Meeting

ORX750 - Centessa

https://www.globenewswire.com/news-release/2025/03/06/3038635/0/en/Centessa-Pharmaceuticals-Announces-Poster-Presentation-of-Phase-1-Clinical-Data-for-ORX750-a-novel-orexin-receptor-2-OX2R-agonist-at-the-American-Academy-of-Neurology-AAN-2025-Annu.html

Mar 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next